Teleflex announced today that Chair, President and CEO Liam Kelly is departing the company, effective immediately.
Teleflex said the decision to move on from Kelly, who had been CEO since January 2018 and chairman since May 2022, is part of its shift to a more focused, higher-growth organization with the planned ...
Teleflex has parted ways with CEO Liam Kelly and is putting a retired board member in charge of the company on an interim ...
Stuart Randle Appointed Interim President and CEOBoard Initiates Search for Permanent CEODr. Stephen Klasko Appointed Chairman of the ...
Teleflex cut its full-year revenue outlook for 2025, citing softer-than-expected demand and order delays. The medical-technologies company on Thursday said it now expects to report revenue of $3.27 ...
Choose Philadelphia Business Journal as a preferred news source to see more of our reporting on Google.
With this transaction, Intersurgical will integrate the Acute Care and Interventional Urology product ranges, technical ...
Teleflex may be enjoying improved profits and sales. But it will still lay off workers and close plants as it restructures in the face of what top executive Benson F. Smith describes as "continuing ...
Teleflex Incorporated presented new clinical data at the 2025 American Urological Association Annual Meeting, highlighting the UroLift™ System as a leading minimally invasive treatment for benign ...
Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, ...
WAYNE, Pa., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that Stuart Randle, a member of the Company’s Board of Directors, has been appointed Interim President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results